Gold prices steady ahead of Fed decision; weekly weakness noted
Organigram Global Inc. submitted a Form 6-K report to the U.S. Securities and Exchange Commission today. The filing, which is a standard requirement for foreign private issuers, pertains to the company’s activities for the month of June 2025. The document includes a Material Change Report dated June 4, 2025, indicating a significant event or development within the company.
Organigram Global Inc., previously known as Organigram Holdings Inc., is classified under the pharmaceutical preparations industry. The company is headquartered at 145 King Street West, Suite 1400, Toronto, Ontario, Canada. The report was signed by Greg Guyatt, Chief Financial Officer of Organigram Global Inc.
This information is based on a press release statement from the company’s SEC filing.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.